Debt Rattle May 31 2023
Home › Forums › The Automatic Earth Forum › Debt Rattle May 31 2023
- This topic has 46 replies, 17 voices, and was last updated 1 year, 4 months ago by zerosum.
-
AuthorPosts
-
June 1, 2023 at 12:31 am #136039boscohorowitzParticipant
“@ Bosco-tastic – TVASF – it ain’t no “prediction”.
It’s an observation of fact.”Everyone is so fucked, including you. It’s a fact. But you seem to glory in it. Weird. It’s like watching chicken little getting all jiggy widdit:
June 1, 2023 at 1:11 am #136040CelticbikerParticipantYou’ve been programmed, your whole life, to not see the elephant in the room. Who prints the money, who owns the media, who has your politicians and judges fuckin kids on tape? It’s not the Amish, shithead.
June 1, 2023 at 1:31 am #136041Veracious PoetParticipantJune 1, 2023 at 1:50 am #136042choochParticipantDr. D,
Here is a link to Lira’s wiki biography page.
https://es.wikipedia.org/wiki/Gonzalo_Lira#Biograf%C3%ADa
He makes the following claim (ref. 12)
Según él durante su estancia en Chile llegó a trabajar una década para la CIA, algo que lo ayudó e influyó en sus futuras novelas.
Translation:
According to him, during his stay in Chile he worked for the CIA for a decade, something that helped him and influenced his future novels.
Hey, maybe he is on the up and up as you believe and hopefully, at the very least, the CIA still owes him favor.
June 1, 2023 at 1:54 am #136043CelticbikerParticipantEverybody knows, jewboy, whose behind those needles.
June 1, 2023 at 4:41 am #136044oxymoronParticipantOk peer reviewed now if anyone wants to rub shit in peoples faces. The more jabs the more covid period. Full stop. Fuck right off.
June 1, 2023 at 1:05 pm #136065zerosumParticipanthttps://www.medrxiv.org/content/10.1101/2022.12.17.22283625v1.full.pdf
Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent VaccineABSTRACT
Background. The purpose of this study was to evaluate whether a bivalent COVID-19 vaccine protects
against COVID-19.
Methods. Employees of Cleveland Clinic in employment on the day the bivalent COVID-19 vaccine
first became available to employees, were included. The cumulative incidence of COVID-19 was
examined over the following weeks. Protection provided by vaccination (analyzed as a time-dependent
covariate) was evaluated using Cox proportional hazards regression. The analysis was adjusted for the
pandemic phase when the last prior COVID-19 episode occurred, and the number of prior vaccine doses
received.
Results. Among 51011 employees, 20689 (41%) had had a previous documented episode of
COVID-19, and 42064 (83%) had received at least two doses of a COVID-19 vaccine. COVID-19
occurred in 2452 (5%) during the study. Risk of COVID-19 increased with time since the most recent prior
COVID-19 episode and with the number of vaccine doses previously received. In multivariable analysis,
the bivalent vaccinated state was independently associated with lower risk of COVID-19 (HR, .70; 95%
C.I., .61-.80), leading to an estimated vaccine effectiveness (VE) of 30% (95% CI, 20-39%). Compared to
last exposure to SARS-CoV-2 within 90 days, last exposure 6-9 months previously was associated with
twice the risk of COVID-19, and last exposure 9-12 months previously with 3.5 times the risk.
Conclusions. The bivalent COVID-19 vaccine given to working-aged adults afforded modest protection
overall against COVID-19, while the virus strains dominant in the community were those represented in
the vaccine -
AuthorPosts
- You must be logged in to reply to this topic.
Sorry, the comment form is closed at this time.